Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
intermediate-acting insulin |
| gptkbp:administeredBy |
short-acting insulin
|
| gptkbp:ATCCode |
A10AC01
|
| gptkbp:color |
cloudy
|
| gptkbp:contains |
zinc
protamine |
| gptkbp:developedBy |
gptkb:B._Norman_Jensen
gptkb:Hans_Christian_Hagedorn |
| gptkbp:duration |
12-18 hours
|
| gptkbp:form |
suspension
|
| https://www.w3.org/2000/01/rdf-schema#label |
Insulin NPH
|
| gptkbp:introducedIn |
1946
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
regulates glucose metabolism
|
| gptkbp:onset |
1-2 hours
|
| gptkbp:otherName |
gptkb:NPH_insulin
isophane insulin |
| gptkbp:peakAction |
4-12 hours
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescribes |
gptkb:type_2_diabetes
type 1 diabetes |
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
allergic reactions lipodystrophy |
| gptkbp:storage |
refrigeration recommended
|
| gptkbp:usedFor |
gptkb:diabetes_mellitus
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:insulin
|
| gptkbp:bfsLayer |
6
|